>
ICSGlobal logo

ICS - ICSGlobal Share Price

A$2.11 0.0  0.0%

Last Trade - 13/05/21

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £12.3m
Enterprise Value £11.4m
Revenue £1.84m
Position in Universe 1438th / 1913
Bullish
Bearish
Unlock ICS Revenue
Momentum
Relative Strength (%)
1m +1.05%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -2.76%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
2.96 3.85 4.90 4.41 5.03 5.69 +13.9%
+50.4 +42.8 +29.1 -60.6 +63.9 +33.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, ICSGlobalLtd revenues decreased from A$3.3M to A$0K. Net loss beforeextraordinary items totaled A$209K vs. income of A$832K.Revenues reflect Other Business Related Financing Revenueremaining flat at A$0K. Net loss reflects Net foreignexchange loss / (gain) decrease from A$40K (income) toA$28K (expense). Basic Earnings per Share excludingExtraordinary Items decreased from A$0.08 to -A$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ICS Revenue Unlock ICS Revenue

Net Income

ICS Net Income Unlock ICS Revenue

Normalised EPS

ICS Normalised EPS Unlock ICS Revenue

PE Ratio Range

ICS PE Ratio Range Unlock ICS Revenue

Dividend Yield Range

ICS Dividend Yield Range Unlock ICS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ICS EPS Forecasts Unlock ICS Revenue
Profile Summary

ICS Global Limited is an investment holding company, which is engaged in the provision of medical billing services, specifically in the United Kingdom. The Company's primary operating business is Medical Billing and Collections (MBC), which is owned and managed by it. The Company provides billing services to the United Kingdom medical consultants and specialists. The MBC service is tailored for both the individual consultant and group practices and is based on its software. MBC caters to all consultants, including those just starting out in private practice, the independent consultants of varying sizes and any specialties, and group practices with multiple providers and clinics. The Company is seeking new investment opportunities. The Company's subsidiaries include Thelma Pty Ltd and Thelma-EU Limited.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2020
Incorporated April 19, 1996
Public Since December 23, 1999
No. of Shareholders: n/a
No. of Employees: 19
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 10,604,019
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ICS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ICS
Upcoming Events for ICS
Frequently Asked Questions for ICSGlobal
What is the ICSGlobal share price?

As of 13/05/21, shares in ICSGlobal are trading at A$2.11, giving the company a market capitalisation of £12.3m. This share price information is delayed by 15 minutes.

How has the ICSGlobal share price performed this year?

Shares in ICSGlobal are currently trading at A$2.11 and the price has moved by 15.93% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ICSGlobal price has moved by -13.23% over the past year.

What are the analyst and broker recommendations for ICSGlobal?

There are no analysts currently covering ICSGlobal.

When will ICSGlobal next release its financial results?

ICSGlobal is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the ICSGlobal dividend yield?

The ICSGlobal dividend yield is 2.13% based on the trailing twelve month period.

Does ICSGlobal pay a dividend?

Last year, ICSGlobal paid a total dividend of 0.05, and it currently has a trailing dividend yield of 2.13%. Looking ahead, ICSGlobal has not announced an ex-dividend date yet.

When does ICSGlobal next pay dividends?

ICSGlobal has yet to annouce their ex-dividend date. The historic dividend yield on ICSGlobal shares is currently 2.13%.

How do I buy ICSGlobal shares?

To buy shares in ICSGlobal you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of ICSGlobal?

Shares in ICSGlobal are currently trading at A$2.11, giving the company a market capitalisation of £12.3m.

Where are ICSGlobal shares listed? Where are ICSGlobal shares listed?

Here are the trading details for ICSGlobal:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: ICS
What kind of share is ICSGlobal?

Based on an overall assessment of its quality, value and momentum, ICSGlobal is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a ICSGlobal share price forecast 2021?

We were not able to load any forecast data for ICSGlobal.

How can I tell whether the ICSGlobal share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ICSGlobal. Over the past six months, the relative strength of its shares against the market has been 14.65%. At the current price of A$2.11, shares in ICSGlobal are trading at 11.44% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the ICSGlobal PE Ratio?

The ICSGlobal PE ratio based on its reported earnings over the past 12 months is 35.65. The shares are currently trading at A$2.11.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of ICSGlobal?

ICSGlobal's management team is headed by:

Garry Chapman - GMG
Gregory Quirk - SEC
Kevin Barry - NEC
James Canning-Ure - NED
Victor Shkolnik - NED
Who are the major shareholders of ICSGlobal?

Here are the top five shareholders of ICSGlobal based on the size of their shareholding:

Pie Funds Management Limited Investment Advisor
Percentage owned: 13.24% (1.39m shares)
Dixson Trust Pty. Ltd. Corporation
Percentage owned: 10.13% (1.07m shares)
King & Svenson Pty. Ltd. Corporation
Percentage owned: 5.94% (626k shares)
Barry (Kevin Charles) Individual Investor
Percentage owned: 5.09% (536k shares)
Timms (William Lewis) Individual Investor
Percentage owned: 4.32% (454k shares)
Similar to ICS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.